Literature DB >> 12467526

Effect of soluble interleukin-6 receptor alpha and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.

E Jablonska1.   

Abstract

BACKGROUND: It has recently been shown that soluble interleukin-6 receptor (sIL-6R) alone or complexed with interleukin (IL)-6, besides their regulatory role in a wide variety of both normal and abnormal biologic reactions mediated by IL-6, could be an effective stimulator of the cell function. AIMS: The key question of the present study is whether the sIL-6Ralpha or sIL-6R with IL-6 released by polymorphonuclear leukocytes (PMN) can influence cytokine secretion such as tumor necrosis factor-alpha (TNF-alpha) by peripheral blood mononuclear cells (PBMC), which together with PMN develop the inflammatory and immune response of a host.
METHODS: Cells were isolated from heparinized whole blood of healthy persons. The PMN were cultured for 1 h at 37 degrees C in 5% CO(2). After incubation, the culture supernatant of PMN was removed and was added to PBMC. The PBMC were cultured for 1 h at 37 degrees C in the same conditions. In the culture supernatants and lysates of PMN, we examined the concentrations of sIL-6R by enzyme-linked immunosorbent assay (ELISA). TNF-alpha was measured at both protein and mRNA levels. Protein levels were determined by ELISA. To examine TNF-alpha mRNA expression, we isolated mRNA from PBMC after culture, using TRIZOL Reagent. The quantity of mRNA TNF-alpha was determined by the Quantikine mRNA assay. RESULTS AND
CONCLUSION: The results obtained revealed that sIL-6R with IL-6 secreted by PMN may play a regulatory role in the immune response by modulating the TNF-alpha expression and its production by PBMC. This may have a significant influence on an early phase of the inflammation and other reactions mediated by TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467526      PMCID: PMC1781675          DOI: 10.1080/09629350210000015746

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  15 in total

1.  IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes.

Authors:  D A Joyce; J H Steer
Journal:  Cytokine       Date:  1996-01       Impact factor: 3.861

2.  Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha.

Authors:  V Modur; Y Li; G A Zimmerman; S M Prescott; T M McIntyre
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

3.  Effect of IL-18 on the release of IL-6 and its soluble receptors: sIL-6Ralpha and sgp130 by human neutrophils.

Authors:  E Jablonska; J Jablonski
Journal:  Immunol Invest       Date:  2002 Aug-Nov       Impact factor: 3.657

4.  Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.

Authors:  J P Gaillard; J C Mani; J Liautard; B Klein; J Brochier
Journal:  Eur Cytokine Netw       Date:  1999-03       Impact factor: 2.737

Review 5.  Interleukin-6 family of cytokines and gp130.

Authors:  T Kishimoto; S Akira; M Narazaki; T Taga
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

6.  Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.

Authors:  P Igaz; A Horváth; B Horváth; C Szalai; E Pállinger; E Rajnavölgyi; S Tóth; S Rose-John; A Falus
Journal:  Immunol Lett       Date:  2000-03-01       Impact factor: 3.685

7.  The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.

Authors:  J Müllberg; W Oberthür; F Lottspeich; E Mehl; E Dittrich; L Graeve; P C Heinrich; S Rose-John
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

8.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.

Authors:  R Schindler; J Mancilla; S Endres; R Ghorbani; S C Clark; C A Dinarello
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

9.  Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism.

Authors:  S Horiuchi; Y Koyanagi; Y Zhou; H Miyamoto; Y Tanaka; M Waki; A Matsumoto; M Yamamoto; N Yamamoto
Journal:  Eur J Immunol       Date:  1994-08       Impact factor: 5.532

10.  The functional role of 55- and 75-kDa tumour necrosis factor receptors in human polymorphonuclear cells in vitro.

Authors:  Y Abe; Y Osuka; T Nakata; Y Kashu; S Kimura
Journal:  Cytokine       Date:  1995-01       Impact factor: 3.861

View more
  1 in total

1.  Role of soluble gp130 in the tumour necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.

Authors:  E Jablonskaca; W Puzewska; M Marcinczyk; J Jablonski
Journal:  Mediators Inflamm       Date:  2003-12       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.